X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-05-01 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $119.91 | -209,157 | 2,719,420 | -7% | -$25,080,696 | ||||||
2026-05-01 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $119.91 | -1,284,876 | 7,607,123 | -14% | -$154,073,682 | ||||||
2026-04-30 | CRWV | Coreweave, Inc. | Magnetar Financial LLC | 10% | S - Sale | $117.84 | -6,564 | 2,737,300 | 0% | -$773,502 | ||||||
2026-04-25 | LASE | Laser Photonics Corp | Lu Qing | Dir | S - Sale | $0.98 | -5,800 | 83,812 | -6% | -$5,684 | ||||||
| M | 2026-04-27 | LASE | Laser Photonics Corp | Lu Qing | Dir | P - Purchase | $0.68 | +69,000 | 83,812 | +466% | +$46,860 | |||||
| D | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | CFO | S - Sale+OE | $71.37 | -12,500 | 97,994 | -11% | -$892,125 | |||||
| D | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | S - Sale+OE | $71.50 | -78,333 | 0 | -100% | -$5,600,701 | |||||
2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Turtle Cameron | CEO | S - Sale | $71.37 | -15,000 | 612,540 | -2% | -$1,070,507 | ||||||
2026-04-30 | ADBE | Adobe Inc. | Forusz Jillian | SVP, CAO | S - Sale | $246.25 | -755 | 3,521 | -18% | -$185,915 | ||||||
2026-05-01 | CCB | Coastal Financial Corp | Hamilton Brian T | Pres of CCBX | S - Sale | $75.44 | -3,079 | 74,571 | -4% | -$232,273 | ||||||
| D | 2026-05-01 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $33.40 | -9,000 | 81,389 | -10% | -$300,560 | |||||
| D | 2026-04-30 | INDI | Indie Semiconductor, Inc. | Aoki Ichiro | Pres | S - Sale+OE | $4.40 | -100,000 | 3,745,531 | -3% | -$440,240 | |||||
| M | 2026-04-29 | DK | Delek Us Holdings, Inc. | Yemin Ezra Uzi | Dir | S - Sale | $46.43 | -105,968 | 692,102 | -13% | -$4,920,289 | |||||
| M | 2026-04-29 | CRWD | Crowdstrike Holdings, Inc. | Kurtz George | Pres, CEO | S - Sale | $446.56 | -5,000 | 2,303,973 | 0% | -$2,232,793 | |||||
| D | 2026-04-29 | CRWV | Coreweave, Inc. | Venturo Brian M | Chief Strategy Officer | S - Sale+OE | $113.24 | -76,924 | 411,446 | -16% | -$8,710,621 | |||||
| D | 2026-04-29 | CRWV | Coreweave, Inc. | Baker Jeff | Principal Accounting Officer | S - Sale+OE | $107.87 | -6,760 | 42,529 | -14% | -$729,201 | |||||
| M | 2026-04-29 | PHVS | Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale | $30.29 | -32,900 | 355,167 | -8% | -$996,545 | |||||
| DM | 2026-04-29 | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $30.23 | -48,300 | 190,419 | -20% | -$1,459,970 | |||||
2026-04-30 | CBK | Commercial Bancgroup, Inc. | Metheny Philip J. | EVP, CFO | P - Purchase | $29.02 | +3,300 | 12,732 | +35% | +$95,760 | ||||||
| D | 2026-04-30 | ODD | Oddity Tech Ltd | Drucker Mann Lindsay | Global CFO | S - Sale+OE | $15.62 | -9,600 | 63,383 | -13% | -$149,952 | |||||
| DM | 2026-04-29 | PHVS | Pharvaris N.V. | Lu Peng | Chief Medical Officer | S - Sale+OE | $30.21 | -18,733 | 66,083 | -22% | -$565,859 | |||||
| M | 2026-04-29 | SCHW | Schwab Charles Corp | Schwab Charles R. | Co-COB | S - Sale | $91.33 | -168,743 | 95,541,831 | 0% | -$15,410,815 | |||||
| D | 2026-05-01 | CVNA | Carvana Co. | Jenkins Mark W. | CFO | S - Sale+OE | $387.19 | -12,750 | 210,127 | -6% | -$4,936,671 | |||||
2026-05-01 | CVNA | Carvana Co. | Palmer Stephen R | VP of Accounting | S - Sale | $395.32 | -1,000 | 32,891 | -3% | -$395,320 | ||||||
| D | 2026-05-01 | CVNA | Carvana Co. | Huston Benjamin E. | COO | S - Sale+OE | $384.96 | -10,000 | 105,962 | -9% | -$3,849,592 | |||||
2026-05-01 | ULS | Ul Solutions Inc. | Scanlon Jennifer F. | Pres, CEO | S - Sale | $91.57 | -12,500 | 277,559 | -4% | -$1,144,596 | ||||||
| D | 2026-05-01 | AVLN | Avalyn Pharma Inc. | Carroll Jill | Dir | P - Purchase | $18.00 | +277,778 | 2,186,562 | +15% | +$5,000,004 | |||||
| D | 2026-05-01 | AVLN | Avalyn Pharma Inc. | Sr One Capital Management, LLC | 10% | P - Purchase | $18.00 | +555,555 | 3,308,649 | +20% | +$9,999,990 | |||||
| D | 2026-05-01 | SLB | Slb Limited/Nv | Gassen Steve Matthew | EVP, Geographies | S - Sale+OE | $56.18 | -53,379 | 53,160 | -50% | -$2,998,766 | |||||
| D | 2026-04-30 | RUSHA | Rush Enterprises Inc Tx | McRoberts Michael | Senior Advisor and Director | S - Sale+OE | $72.23 | -8,000 | 16,229 | -33% | -$577,854 | |||||
2026-05-01 | IMVT | Immunovant, Inc. | Susman Robert Graham | Dir | S - Sale | $27.17 | -2,502 | 36,394 | -6% | -$67,979 | ||||||
| D | 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale+OE | $63.88 | -5,000 | 236,984 | -2% | -$319,384 | |||||
2026-05-01 | SFM | Sprouts Farmers Market, Inc. | Lombardi Brandon F. | GC | S - Sale | $82.04 | -406 | 6,801 | -6% | -$33,307 | ||||||
2026-04-30 | GOOGL | Alphabet Inc. | Arnold Frances | Dir | S - Sale | $371.00 | -102 | 22,263 | 0% | -$37,842 | ||||||
2026-04-30 | SBMT | Silver Bow Mining Corp. | Naugle Charles Travis | CEO | P - Purchase | $9.88 | +5,000 | 148,799 | +3% | +$49,409 | ||||||
| D | 2026-05-01 | RSI | Rush Street Interactive, Inc. | Schwartz Richard Todd | CEO | S - Sale+OE | $28.13 | -158,335 | 7,766,725 | -2% | -$4,454,423 | |||||
2026-04-30 | PEBK | Peoples Bancorp of North Carolina Inc | Abernethy James S | Dir | S - Sale | $39.35 | -600 | 176,067 | 0% | -$23,610 | ||||||
2026-05-01 | CXW | Corecivic, Inc. | Carter, Cole G. | Chief Administrative Officer | S - Sale | $20.64 | -12,500 | 228,383 | -5% | -$258,000 | ||||||
| D | 2026-05-01 | RSI | Rush Street Interactive, Inc. | Stetz Mattias | COO | S - Sale+OE | $28.09 | -20,000 | 1,655,400 | -1% | -$561,878 | |||||
| M | 2026-04-29 | AXR | Amrep Corp. | Dahl James H | 10% | P - Purchase | $27.78 | +8,000 | 983,998 | +1% | +$222,257 | |||||
2026-04-29 | BANF | Bancfirst Corp /Ok/ | Rainbolt David E | Dir, 10% | S - Sale | $115.00 | -1 | 4,948,448 | 0% | -$115 | ||||||
2026-05-01 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $6.23 | -16,667 | 1,193,173 | -1% | -$103,805 | ||||||
2026-05-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale | $16.76 | -5,394 | 26,453 | -17% | -$90,407 | ||||||
| DM | 2026-04-30 | USCB | Uscb Financial Holdings, Inc. | Wycoff W Kirk | 10% | S - Sale+OE | $18.25 | -50,000 | 1,813,786 | -3% | -$912,514 | |||||
2026-05-01 | CTNM | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | S - Sale | $13.12 | -4,170 | 150,384 | -3% | -$54,694 | ||||||
2026-05-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $56.83 | -2,250 | 160,744 | -1% | -$127,870 | ||||||
2026-05-01 | IRT | Independence Realty Trust, Inc. | Gebert Richard D | Dir | S - Sale | $16.33 | -500 | 37,372 | -1% | -$8,165 | ||||||
2026-04-29 | CVLG | Covenant Logistics Group, Inc. | Kramer D Michael | Dir | S - Sale | $34.72 | -2,650 | 19,536 | -12% | -$92,009 | ||||||
2026-04-30 | UNM | Unum Group | Ahmed Elizabeth Claire | EVP, People, Communications | S - Sale | $80.14 | -12,000 | 42,587 | -22% | -$961,680 | ||||||
2026-04-29 | BE | Bloom Energy Corp | Soderberg Shawn Marie | See Remarks | S - Sale | $279.00 | -35,000 | 482,463 | -7% | -$9,765,000 | ||||||
2026-05-01 | PJT | Pjt Partners Inc. | Meates Helen T | CFO | S - Sale | $153.20 | -8,000 | 58,466 | -12% | -$1,225,560 | ||||||
2026-04-29 | LNWO | Light & Wonder, Inc. | Fine Capital Partners, L.P. | 10% | S - Sale | $82.44 | -80,000 | 7,679,792 | -1% | -$6,595,424 | ||||||
| D | 2026-05-01 | FENC | Fennec Pharmaceuticals Inc. | Raykov Rosty | Dir | S - Sale+OE | $6.47 | -10,781 | 121,451 | -8% | -$69,753 | |||||
| D | 2026-04-30 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $572.63 | -9,500 | 679,797 | -1% | -$5,439,991 | |||||
| D | 2026-04-30 | UTHR | United Therapeutics Corp | Edgemond James | CFO, TREASURER | S - Sale+OE | $572.61 | -10,000 | 18,876 | -35% | -$5,726,062 | |||||
| D | 2026-04-30 | TXN | Texas Instruments Inc | Gary Mark | SVP | S - Sale+OE | $279.25 | -13,689 | 45,547 | -23% | -$3,822,671 | |||||
| D | 2026-04-30 | TXN | Texas Instruments Inc | Roberts Mark T. | SVP | S - Sale+OE | $280.34 | -28,080 | 53,809 | -34% | -$7,871,934 | |||||
2026-05-01 | ROG | Rogers Corp | Larabee Brian Keith | SVP, GM - EMS | S - Sale | $135.91 | -830 | 5,515 | -13% | -$112,805 | ||||||
2026-04-30 | CR | Crane Co | Lynch Susan D | Dir | P - Purchase | $177.38 | +150 | 370 | +68% | +$26,607 | ||||||
| D | 2026-05-01 | GEVO | Gevo, Inc. | Shafer Andrew | Chief Cust Mkt, Brnd Officer | S - Sale+OE | $2.00 | -5,550 | 287,688 | -2% | -$11,103 | |||||
| D | 2026-04-30 | SXT | Sensient Technologies Corp | Morris Steven B | Pres, Color Group | S - Sale+OE | $114.58 | -200 | 7,935 | -2% | -$22,915 | |||||
2026-04-29 | KALU | Kaiser Aluminum Corp | Grimley Richard P. | Dir | S - Sale | $171.52 | -1,524 | 4,578 | -25% | -$261,396 | ||||||
| DM | 2026-04-30 | GSBC | Great Southern Bancorp, Inc. | Copeland Rex A | Treasurer | S - Sale+OE | $68.41 | -2,950 | 25,921 | -10% | -$201,813 | |||||
| D | 2026-04-29 | ETSY | Etsy Inc | Silverman Josh | Executive Chair of the Board | S - Sale+OE | $69.00 | -36,443 | 358,791 | -9% | -$2,514,567 | |||||
2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres Research, Development | P - Purchase | $2.69 | +1,706 | 16,229 | +12% | +$4,589 | ||||||
2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Skibsted Russell | CFO | P - Purchase | $2.69 | +2,190 | 6,498 | +51% | +$5,891 | ||||||
| M | 2026-04-29 | AVTX | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | CFO | S - Sale | $13.16 | -16,915 | 423 | -98% | -$222,589 | |||||
2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO | P - Purchase | $2.69 | +2,034 | 10,301 | +25% | +$5,471 | ||||||
2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.69 | +1,511 | 7,976 | +23% | +$4,065 | ||||||
| M | 2026-04-29 | VINP | Vinci Compass Investments Ltd. | Ribeiro Sergio Passos | CFO | S - Sale | $10.87 | -3,322 | 766,248 | 0% | -$36,126 | |||||
2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Guy Wendy | Chief Administrative Officer | P - Purchase | $2.69 | +1,748 | 6,774 | +35% | +$4,702 | ||||||
| D | 2026-04-30 | GSBC | Great Southern Bancorp, Inc. | Turner Joseph W | Pres, CEO, 10% | S - Sale+OE | $68.16 | -6,000 | 538,356 | -1% | -$408,962 | |||||
| M | 2026-04-29 | VINP | Vinci Compass Investments Ltd. | Lovisotto Fernando | Head of Global IP, S | S - Sale | $10.87 | -9,232 | 1,100,539 | -1% | -$100,396 | |||||
2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Botta Nicholas Anthony | Trustee | P - Purchase | $50.00 | +250,000 | 250,000 | New | +$12,500,000 | ||||||
2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Officer | P - Purchase | $2.69 | +1,986 | 7,763 | +34% | +$5,342 | ||||||
| M | 2026-04-29 | VINP | Vinci Compass Investments Ltd. | Zaremba Bruno Augusto Sacchi | Pres Finance, Operations | S - Sale | $10.90 | -13,980 | 1,128,333 | -1% | -$152,341 | |||||
| M | 2026-04-29 | RELY | Remitly Global, Inc. | Hug Joshua | Dir | S - Sale | $21.61 | -33,600 | 3,816,703 | -1% | -$726,096 | |||||
| D | 2026-05-01 | KNSA | Kiniksa Pharmaceuticals International, Plc | Patel Sanj K | COB, CEO | S - Sale+OE | $54.02 | -48,565 | 237,763 | -17% | -$2,623,481 | |||||
| D | 2026-04-29 | AUID | Authid Inc. | Garchik Stephen Jeffrey | Dir, 10% | P - Purchase | $1.25 | +120,482 | 1,643,481 | +8% | +$150,000 | |||||
| D | 2026-04-30 | NUVL | Nuvalent, Inc. | Miller Deborah Ann | GC | S - Sale+OE | $99.22 | -5,500 | 59,634 | -8% | -$545,691 | |||||
2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Coussin Halit | Chief Compliance Officer | P - Purchase | $50.00 | +200,000 | 200,000 | New | +$10,000,000 | ||||||
| D | 2026-04-29 | AUID | Authid Inc. | Jisser Ken | Dir | P - Purchase | $1.25 | +30,120 | 122,245 | +33% | +$37,499 | |||||
2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Hakim Ben | Pres | P - Purchase | $50.00 | +350,000 | 350,000 | New | +$17,500,000 | ||||||
2026-05-01 | FFBC | First Financial Bancorp /Oh/ | Davis Claude E | Chair of the Board | S - Sale | $30.45 | -26,123 | 30,410 | -46% | -$795,445 | ||||||
| M | 2026-04-29 | VTIX | Virtuix Holdings Inc. | Goetgeluk Jan Roger | CEO | S - Sale | $3.35 | -32,259 | 4,121,888 | -1% | -$108,185 | |||||
2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Israel Ryan | Chief Investment Officer | P - Purchase | $50.00 | +500,000 | 500,000 | New | +$25,000,000 | ||||||
| D | 2026-04-29 | NUVL | Nuvalent, Inc. | Noci Darlene | Chief Development Officer | S - Sale+OE | $99.55 | -5,500 | 58,117 | -9% | -$547,524 | |||||
2026-04-29 | KALU | Kaiser Aluminum Corp | Harvey Keith | Pres, CEO | S - Sale | $173.13 | -3,031 | 94,308 | -3% | -$524,757 | ||||||
| E | 2026-04-30 | FIX | Comfort Systems USA Inc | Mercado, Pablo G. | Dir | S - Sale | $3.56 | -500 | 3,000 | -14% | -$1,780 | |||||
| D | 2026-04-29 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $65.19 | -2,172 | 93,216 | -2% | -$141,595 | |||||
2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Falzone Jessica A | Secretary | P - Purchase | $50.00 | +2,000 | 2,000 | New | +$100,000 | ||||||
2026-04-30 | PSUS | Pershing Square Usa, Ltd. | Gonnella Michael | CFO | P - Purchase | $50.00 | +100,000 | 100,000 | New | +$5,000,000 | ||||||
| D | 2026-04-30 | COCO | Vita Coco Company, Inc. | Kirban Michael | Exec COB | S - Sale+OE | $68.00 | -50,000 | 2,138,529 | -2% | -$3,400,000 | |||||
| D | 2026-04-29 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $65.19 | -392 | 34,942 | -1% | -$25,555 | |||||
2026-05-01 | FCFS | Firstcash Holdings, Inc. | Garrett Paula K | Dir | S - Sale | $217.40 | -1,500 | 6,564 | -19% | -$326,100 | ||||||
2026-05-01 | BX | Blackstone Inc. | Sawhney Vikrant | Chief Administrative Officer | S - Sale | $125.79 | -30,014 | 917,269 | -3% | -$3,775,565 | ||||||
| DM | 2026-04-29 | COCO | Vita Coco Company, Inc. | Burth Jonathan | COO | S - Sale+OE | $65.00 | -60,000 | 57,910 | -51% | -$3,900,000 | |||||
| D | 2026-04-29 | MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | S - Sale+OE | $25.37 | -7,500 | 10,503 | -42% | -$190,299 | |||||
2026-04-30 | ACT | Enact Holdings, Inc. | Genworth Holdings, Inc. | 10% | S - Sale | $42.55 | -560,453 | 112,809,079 | 0% | -$23,848,452 | ||||||
2026-04-30 | LMB | Limbach Holdings, Inc. | Brooks Jayme L. | CFO | S - Sale | $100.00 | -3,440 | 129,124 | -3% | -$344,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |